Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
66.7%
% of FBT's 31 holdings also in XBI
16.9%
% of XBI's 119 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.3% | 2.8% | 2.8% |
|
VERTEX PHARMACEUTICALS INC | 3.4% | 2.7% | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 3.3% | 2.7% | 2.7% |
|
NEUROCRINE BIOSCIENCES INC | 3.7% | 2.6% | 2.6% |
|
UNITED THERAPEUTICS CORP | 3.4% | 2.6% | 2.6% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to XBI
 |
GENMAB A/S SPONSORED ADR | 3.5% |
|
REPLIGEN CORP | 3.5% |
 |
ARGENX SE ADR | 3.4% |
 |
BIONTECH SE SPONSORED ADR | 3.4% |
|
BEIGENE LTD. SPONSORED ADR | 3.3% |
|
WATERS CORP | 3.3% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.2% |
|
ILLUMINA INC | 3.2% |
|
BRUKER CORP | 3.1% |
|
CORCEPT THERAPEUTICS INC | 3.0% |
FBT Underweight Relative to XBI
|
INSMED INC | -2.7% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.3% |
|
ABBVIE INC | -2.3% |
|
BLUEPRINT MEDICINES CORP. | -2.2% |
|
TG THERAPEUTICS INC | -1.8% |
|
BRIDGEBIO PHARMA, INC. | -1.8% |
|
REVOLUTION MEDICINES, INC. | -1.5% |
|
CYTOKINETICS INC | -1.5% |
|
SUMMIT THERAPEUTICS INC | -1.4% |
|
CRISPR THERAPEUTICS AG | -1.4% |